Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1075 | Pituitary - Clinical | ECE2017

The E in POEMS syndrome: what to expect?

Caimari Francisca , D'Sa Shirley , Lunn Michael , Baldeweg Stephanie E

Introduction: POEMS syndrome is a rare multisystemic disorder including polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma-proliferative disorder and skin changes. We aim to describe the course of the endocrine disease in the context of this paraneoplastic syndrome.Methods: 69 patients with POEMS have been under the MDT care in our hospital. Data is currently available for 32 patients who attended the joint haematological/neurological/endocr...

ea0099ep739 | Adrenal and Cardiovascular Endocrinology | ECE2024

Surgical management of adrenal masses: experience of a tertiary center

Santos Sara , Saraiva Miguel , Marques Puga Francisca , Palma Isabel

Introduction: Adrenal masses (AM) are being increasingly diagnosed but only a small portion will need surgical treatment.Methods: We retrospectively reviewed patients referred to the Endocrinology Clinic that underwent adrenalectomy between 1996 and 2023.Results: We included 57 patients. Most AM were diagnosed incidentally (53%) and had a median size of 32 (25) mm. Forty (70%) patients had hormonal hypersecretion (HH): pheocromocyt...

ea0099ep746 | Adrenal and Cardiovascular Endocrinology | ECE2024

When two rare conditions come together

Leitao Francisca , Quitalo Ana , Carlos Cordeiro Maria , Raimundo Luisa

Introduction: Deficiency of 11-beta hydroxylase (11-HD) accounts for 5% of the causes of congenital adrenal hyperplasia (CAH), with an incidence of 1:100,000. The classic form phenotype consists in an excess of androgens and mineralocorticoids, which clinically translates into hypertension and hypokalaemia. In boys, there may be an increase in penis size, early adrenarche, increased growth velocity, and advancing bone age.Clinical case: We present a case...

ea0099rc10.4 | Rapid Communications 10: Calcium and Bone | Part II | ECE2024

Increased bone fragility over time in women with chronic hypoparathyroidism: Real-world data from the HypoparaNet Italian Cohort

Giusti Francesca , Marini Francesca , Weiss Blandine , Ovize Michel , Benvenga Salvatore , Cetani Filomena , Colao Annamaria , Corbetta Sabrina , Degli Uberti Ettore , Iacobone Maurizio , Lenzi Andrea , Mantovani Giovanna , Maddalena Rmggeri Rosaria , Brandi Maria Luisa

Introduction: The HypoparaNet database includes 509 patients (110 men and 399 women) with chronic hypoparathyroidism (cHP), recruited and followed in 20 clinical centers in Italy from 2014 onwards. cHP etiology included 363 post-surgical cases (71.3%), 78 idiopathic cases (15.3%), and 64 patients with a genetic background (12.6%). Bone health is an important clinical aspect to be considered in patients with cHP, whose skeleton is exposed both to the cHP-induced alteration of b...

ea0099p396 | Late-Breaking | ECE2024

Growth hormone-releasing hormone (GHRH) antagonists enhance radiosensitivity in non-small cell lung cancer cells

Gesmundo Iacopo , Pedrolli Francesca , Romana Giglioli Francesca , Bertoldo Alessia , Gregorc Vanesa , Sapino Anna , Righi Luisella , Cai Renzhi , Sha Wei , Giulio Papotti Mauro , Ghigo Ezio , V. Schally Andrew , Ricardi Umberto , Granata Riccarda

Growth hormone-releasing hormone (GHRH), apart from stimulating GH secretion in the pituitary, exerts many peripheral functions, including stimulation of cell proliferation and survival. In fact, GHRH and GHRH receptors (GHRH-Rs) are expressed in different cancer cell types, where they promote proliferation and survival. Conversely, GHRH antagonists exert antineoplastic activities in several tumors, including lung cancer, one of the leading causes of death by cancer worldwide....

ea0081p285 | Adrenal and Cardiovascular Endocrinology | ECE2022

Prognostic value of endocrine biomarkers in patients admitted to intensive care unit for COVID-19

Varaldo Emanuele , Maria Berton Alessandro , Rosata Andrea , Montrucchio Giorgia , Rumbolo Francesca , Prencipe Nunzia , Ghigo Ezio , Brazzi Luca , Grottoli Silvia

Introduction: To date, there are no clear biochemical parameters to identify early COVID-19 cases at risk of complications in the Intensive Care Unit (ICU). Aim: To evaluate the prognostic potential of endocrine biomarkers associated with acute inflammatory conditions in ICU patients for COVID-19.Methods: Between 1/3/2020 and 31/12/2020 we recruited 126 consecutive patients at the admission to ICU 1U, Molinette University Hospital ...

ea0081p566 | Calcium and Bone | ECE2022

High prevalence of thoracic vertebral fractures in patients with medullary thyroid cancer

Di Filippo Luigi , Albanese Lucrezia , Castellino Laura , Doga Mauro , Formenti Anna Maria , Frara Stefano , Perticone Francesca , Giustina Andrea

Medullary thyroid cancer (MTC) is a rare malignancy of the thyroid gland. MTCs originate from thyroid-C cells and account for 2-4% of all thyroid neoplasms. Originating from thyroid-C cells, the main secretory product of MTCs is calcitonin, used as sensitive and specific MTC-biomarker. Calcitonin is a hormone known to participate in calcium-bone metabolism suppressing bone-resorption by inhibiting the activity of osteoclasts, and inhibiting the kidney reabsorption of calcium a...

ea0081p412 | Pituitary and Neuroendocrinology | ECE2022

Sodium alterations impair the long-term prognosis of hospitalized patients with COVID-19 pneumonia: hospital readmissions and mortality rates after a 18-month follow-up

Martino Marianna , Aboud Nairus , Perrone Michele , Falcioni Paolo , Giancola Giulia , Ciarloni Alessandro , Salvio Gianmaria , Silvetti Francesca , Taccaliti Augusto , Arnaldi Giorgio

Background: Dysnatremia is common in hospitalized patients, often worsening the prognosis in pneumopathies and critical illnesses, such as COVID-19. Here, hyponatremia is an indicator of pulmonary involvement, while hypernatremia is associated with worse assistance outcomes, particularly when resulting from an overcorrected hyponatremia. Longer hospitalizations, readmissions after discharge and higher short- and long-term mortality rates have been observed in acute patients ex...

ea0081p436 | Pituitary and Neuroendocrinology | ECE2022

Growth hormone-releasing hormone (GHRH) promotes survival and proliferation of neural stem cells and reduces amyloid-β-induced toxicity

Pedrolli Francesca , Banfi Dana , Gesmundo Iacopo , Guglielmotto Michela , Tamagno Elena , Schally Andrew V. , Ghigo Ezio , Granata Riccarda

Neurogenesis, the process by which new neurons are generated from precursors, persists in discrete regions of the adult hippocampus. The hippocampus is critical for learning and memory and is the main target of Alzheimer’s Disease (AD), which causes massive neuronal death, reduction in neurogenesis, and impairment in cognitive functions. Therefore, preventing neuronal loss or increasing the production of new neurons may represent a potential therapeutic strategy to reduce...

ea0081p701 | Reproductive and Developmental Endocrinology | ECE2022

Evolution of congenital hypothyroidism with in situ thyroid gland in children and adolescents

Pignata Luisa , Bagattini Brunella , Montanelli Lucia , Agretti Patrizia , De Marco Giuseppina , Ferrarini Eleonora , Orsolini Francesca , Tonacchera Massimo

Background: In recent years, increasing cases of congenital hypothyroidism (CH) with in situ thyroid gland are identified. Outcome of children affected from CH with normally sited thyroid of normal size is still unknown. The objective of our study is to describe the natural history of this specific form of CH. Patients and methods: We retrospectively evaluated clinical, biochemical and instrumental data of 74 patients with diagnosis of CH with in situ thyroid...